Collagen Dental Wound Dressing - Bovine Dermis Tap, 25mm x 75mm Product was distributed under ...

FDA Device Recall #Z-1777-2022 — Class II — August 3, 2022

Recall Summary

Recall Number Z-1777-2022
Classification Class II — Moderate risk
Date Initiated August 3, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Collagen Matrix Inc
Location Oakland, NJ
Product Type Devices
Quantity 1336 units

Product Description

Collagen Dental Wound Dressing - Bovine Dermis Tap, 25mm x 75mm Product was distributed under the following brand names: 1) Cytoplast RTMTAPE, 25mm x 75mm 2) GIBSON Healthcare, 25mm x 75mm 3) MaxxTape, 2.5cm x 7.5cm x 0.1cm 4) NEOTAPE, 25mm x 75mm 5) Karl Schumacher TAPE, 2.5cm x 7.5cm x 1mm

Reason for Recall

The packaging may not be sealed, which could compromise sterility.

Distribution Pattern

US distribution to distributors in IL, IN, MI, NC, OH, and TX

Lot / Code Information

1) UDI (1 unit package): +D765RTMTAPE100/$$3250131E1C0070AJ; (10 units package): +D765RTMTAPE101/$$3250131E1C0080AK Cytoplast RTMTAPE, Lot E1C0070A 2) UDI (1 unit package): (01)00366975012616(17)250131(10)BDDWTU211002; (10 units package): (01)10366975012613(17)250131(10)BDDWTU211002 GIBSON Healthcare, REF 5251-194; Lot BDDWTU211002 3) UDI (1 unit package): (01)00813954023571(17)250131(10)BDDWTU211002; (10 units package): (01)10813954023578(17)250131(10)BDDWTU211002 MaxxTape, Ref: XTAPE; Lot BDDWTU211002 4) UDI (1 unit package): (01)00813954022079(17)250131(10)BDDWTU211002; (5 units package): (01)10813954022076(17)250131(10)BDDWTU211002 NEOTAPE, Lot BDDWTU211002 5) UDI (1 unit package): (01)00842517100084(17)250131(10)BDDWTU211002; (10 units package): (01)00842517100077(17)250131(10)BDDWTU211002 Karl Schumacher Dental, REF RCWT0001; Lot BDDWTU211002

Other Recalls from Collagen Matrix Inc

Recall # Classification Product Date
Z-0911-2020 Class II GIBSON Healthcare Membrane Extended, 20mm x 30m... Nov 5, 2019
Z-0910-2020 Class II GIBSON Healthcare Membrane Extended, 15mm x 20m... Nov 5, 2019
Z-0907-2020 Class II GIBSON Healthcare Membrane 6-9, 15mm x 20mm, Re... Nov 5, 2019
Z-0909-2020 Class II GIBSON Healthcare Membrane 6-9, 30mm x 40mm, Re... Nov 5, 2019
Z-0908-2020 Class II GIBSON Healthcare Membrane 6-9, 20mm x 30mm, Re... Nov 5, 2019

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.